vs
ASP Isotopes Inc.（ASPI）与华米科技（ZEPP）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是华米科技的1.6倍（$16.7M vs $10.5M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
华米科技（Zepp Health）是全球知名的智能可穿戴设备与数字健康解决方案提供商，核心产品包括智能手表、运动手环、AI健康监测工具，面向个人消费者、体育机构及医疗合作伙伴，提供健康追踪、远程健康管理等服务。
ASPI vs ZEPP — 直观对比
营收规模更大
ASPI
是对方的1.6倍
$10.5M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $10.5M |
| 净利润 | — | $-223.0K |
| 毛利率 | 12.5% | 38.2% |
| 营业利润率 | — | -1.2% |
| 净利率 | — | -2.1% |
| 营收同比 | 1295.7% | — |
| 净利润同比 | -586.8% | — |
| 每股收益（稀释后） | — | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIZEPP
| Q4 25 | $16.7M | — | ||
| Q3 25 | $4.9M | $10.5M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $5.3M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | — | $5.6M | ||
| Q1 24 | — | $5.5M | ||
| Q3 23 | — | $11.4M |
净利润ASPIZEPP
| Q4 25 | — | — | ||
| Q3 25 | $-12.9M | $-223.0K | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-2.0M | ||
| Q3 23 | — | $52.6K |
毛利率ASPIZEPP
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | 38.2% | ||
| Q2 25 | — | 36.2% | ||
| Q1 25 | — | 37.3% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | — | 40.3% | ||
| Q1 24 | — | 36.8% | ||
| Q3 23 | — | 33.9% |
营业利润率ASPIZEPP
| Q4 25 | — | — | ||
| Q3 25 | -306.1% | -1.2% | ||
| Q2 25 | — | -10.3% | ||
| Q1 25 | — | -47.7% | ||
| Q3 24 | — | -29.5% | ||
| Q2 24 | — | -24.3% | ||
| Q1 24 | — | -39.6% | ||
| Q3 23 | — | — |
净利率ASPIZEPP
| Q4 25 | — | — | ||
| Q3 25 | -263.7% | -2.1% | ||
| Q2 25 | — | -13.0% | ||
| Q1 25 | — | -51.2% | ||
| Q3 24 | — | -31.2% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | — | -36.8% | ||
| Q3 23 | — | 0.5% |
每股收益（稀释后）ASPIZEPP
| Q4 25 | — | — | ||
| Q3 25 | $-0.15 | $-0.01 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.17 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.01 | ||
| Q3 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $8.7M |
| 总债务越低越好 | $14.4M | $9.6M |
| 股东权益账面价值 | $204.2M | $31.2M |
| 总资产 | $498.0M | $80.9M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.31× |
8季度趋势，按日历期对齐
现金及短期投资ASPIZEPP
| Q4 25 | $333.3M | — | ||
| Q3 25 | $113.9M | $8.7M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $10.7M | ||
| Q3 24 | — | $16.4M | ||
| Q2 24 | — | $17.0M | ||
| Q1 24 | — | $17.9M | ||
| Q3 23 | — | $17.9M |
总债务ASPIZEPP
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | $9.6M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $9.6M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $11.2M | ||
| Q3 23 | — | $16.3M |
股东权益ASPIZEPP
| Q4 25 | $204.2M | — | ||
| Q3 25 | $74.1M | $31.2M | ||
| Q2 25 | — | $31.1M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $44.6M | ||
| Q1 24 | — | — | ||
| Q3 23 | — | $48.0M |
总资产ASPIZEPP
| Q4 25 | $498.0M | — | ||
| Q3 25 | $225.9M | $80.9M | ||
| Q2 25 | — | $75.8M | ||
| Q1 25 | — | $71.6M | ||
| Q3 24 | — | $81.3M | ||
| Q2 24 | — | $79.7M | ||
| Q1 24 | — | $80.5M | ||
| Q3 23 | — | $91.4M |
负债/权益比ASPIZEPP
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | 0.31× | ||
| Q2 25 | — | 0.31× | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | 0.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPIZEPP
| Q4 25 | $-37.8M | — | ||
| Q3 25 | $-8.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
自由现金流ASPIZEPP
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
自由现金流率ASPIZEPP
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
资本支出强度ASPIZEPP
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
